Literature DB >> 17200336

Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas.

Jinghua Tsai Chang1, Han Chang, Po-Hung Chen, Shong-Ling Lin, Pinpin Lin.   

Abstract

PURPOSE: CYP1B1 and CYP1A1 expression is up-regulated by activation of the aryl hydrocarbon receptor (AhR) through binding of ligands such as cigarette smoke components. We examined the association between AhR, CYP1B1, and CYP1A1 expression in noninvasive bronchioloalveolar carcinomas (BAC) and lung adenocarcinomas and investigated the effects of AhR overexpression on cell physiology. EXPERIMENTAL
DESIGN: AhR, CYP1B1, and CYP1A1 expression was examined in 107 lung adenocarcinomas and 57 BAC by immunohistochemistry. AhR expression in lung adenocarcinoma H1355 cells was stably reduced by RNA interference (RNAi). AhR, CYP1B1, and CYP1A1 expression was examined using real-time reverse transcription-PCR. Cell physiology was evaluated by measuring anchorage-independent growth and intracellular reactive oxygen species.
RESULTS: Expression of AhR and CYP1A1 was associated in smoking adenocarcinoma patients, whereas expression of AhR and CYP1B1 was associated regardless of smoking status. The level of CYP1B1, but not CYP1A1, was positively associated with AhR overexpression in BAC. 2,3,7,8-Tetrachlorobenzo-p-dioxin-induced CYP1A1/1B1 expression was reduced in AhR RNAi clones. In the absence of 2,3,7,8-tetrachlorobenzo-p-dioxin, CYP1B1 mRNA levels were reduced in AhR RNAi clones, whereas CYP1A1 mRNA levels were barely detectable. Furthermore, anchorage-independent growth and intracellular oxidative stress were significantly reduced in AhR RNAi cells.
CONCLUSIONS: In the absence of exogenous AhR ligands (such as cigarette smoke components), AhR overexpression up-regulated the expression of CYP1B1 in the early stage of lung adenocarcinoma. Elevated AhR expression in lung adenocarcinoma cells could increase intracellular oxidative stress and promote cell growth, implying that disrupting AhR expression might prevent the early development of lung adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200336     DOI: 10.1158/1078-0432.CCR-06-1166

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  32 in total

1.  Applications of CYP-450 expression for biomonitoring in environmental health.

Authors:  Ho-Sun Lee; Mihi Yang
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

2.  Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users.

Authors:  Min-Ae Song; Jo L Freudenheim; Theodore M Brasky; Ewy A Mathe; Joseph P McElroy; Quentin A Nickerson; Sarah A Reisinger; Dominic J Smiraglia; Daniel Y Weng; Kevin L Ying; Mark D Wewers; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-17       Impact factor: 4.254

3.  Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice.

Authors:  Sergio Portal-Nuñez; Uma T Shankavaram; Mahadev Rao; Nicole Datrice; Scott Atay; Marta Aparicio; Kevin A Camphausen; Pedro M Fernández-Salguero; Han Chang; Pinpin Lin; David S Schrump; Stavros Garantziotis; Frank Cuttitta; Enrique Zudaire
Journal:  Cancer Res       Date:  2012-09-19       Impact factor: 12.701

4.  Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic marker.

Authors:  Ryoko Saito; Yasuhiro Miki; Shuko Hata; Kiyoshi Takagi; Shinya Iida; Yuki Oba; Katsuhiko Ono; Takanori Ishida; Takashi Suzuki; Noriaki Ohuchi; Hironobu Sasano
Journal:  Horm Cancer       Date:  2014-02       Impact factor: 3.869

Review 5.  Prenatal environmental exposures, epigenetics, and disease.

Authors:  Frederica Perera; Julie Herbstman
Journal:  Reprod Toxicol       Date:  2011-01-20       Impact factor: 3.143

6.  Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk.

Authors:  Timothy R Church; Majda Haznadar; Mindy S Geisser; Kristin E Anderson; Neil E Caporaso; Chap Le; Salwan B Abdullah; Stephen S Hecht; Martin M Oken; Brian Van Ness
Journal:  Int J Mol Epidemiol Genet       Date:  2010-08-05

7.  Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study.

Authors:  Chun Liu; Xiang-Dong Wang; Lorelei Mucci; J Michael Gaziano; Shumin M Zhang
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

8.  Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons.

Authors:  Mark J Roth; Wen-Qiang Wei; Jessica Baer; Christian C Abnet; Guo-Qing Wang; Lawrence R Sternberg; Andrew C Warner; Laura Lee Johnson; Ning Lu; Carol A Giffen; Sanford M Dawsey; You-Lin Qiao; James Cherry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

9.  Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma.

Authors:  Kwang-Yu Chang; Meng-Ru Shen; Mei-Yi Lee; Wen-Lin Wang; Wu-Chou Su; Wen-Chang Chang; Ben-Kuen Chen
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.